{
  "cik": 1991792,
  "cik_padded": "0001991792",
  "entityName": "CG Oncology, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-079498",
      "filed": "2026-02-27",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 134000.0,
        "cash": 32490000.0,
        "eps_diluted": -2.08,
        "free_cash_flow": -132480000.0,
        "net_income": -160995000.0,
        "operating_cash_flow": -132346000.0,
        "operating_income": -190774000.0,
        "revenue": 4040000.0,
        "stockholders_equity": 752602000.0,
        "total_assets": 791592000.0,
        "total_liabilities": 38990000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05180693115351806,
        "revenue_growth_yoy": 2.546971027216857,
        "roa_avg2y": -0.20822057063261573,
        "roa_period_end": -0.20338128732983654,
        "roe_avg2y": -0.2166854309515814,
        "roe_period_end": -0.2139178476804473
      }
    },
    {
      "accn": "0001193125-26-079498",
      "filed": "2026-02-27",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 234000.0,
        "cash": 257068000.0,
        "eps_diluted": -1.41,
        "free_cash_flow": -78947000.0,
        "net_income": -88039000.0,
        "operating_cash_flow": -78713000.0,
        "operating_income": -114666000.0,
        "revenue": 1139000.0,
        "stockholders_equity": 733377000.0,
        "total_assets": 754797000.0,
        "total_liabilities": 21420000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.02920735174405524,
        "revenue_growth_yoy": 4.583333333333333,
        "roa_avg2y": -0.18454917629006665,
        "roa_period_end": -0.11663930831733565,
        "roe_avg2y": -0.2885214419026114,
        "roe_period_end": -0.12004603362254337
      }
    },
    {
      "accn": "0001193125-26-079498",
      "filed": "2026-02-27",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 8266000.0,
        "eps_diluted": -15.65,
        "net_income": -48607000.0,
        "operating_cash_flow": -45679000.0,
        "operating_income": -55449000.0,
        "revenue": 204000.0,
        "stockholders_equity": -123100000.0,
        "total_assets": 199301000.0,
        "total_liabilities": 14511000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.24388738641552224,
        "roe_avg2y": 0.4841503438864901
      }
    },
    {
      "accn": "0001193125-26-079498",
      "filed": "2026-02-27",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -77693000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-079498",
    "filed": "2026-02-27",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001991792.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001991792.json"
  },
  "ticker": "CGON"
}